Professor Jane Armitage
Professor Armitage’s main research interests are in lipids and the epidemiology of cardiovascular and other chronic diseases including osteoporosis. She also has particular experience in respiratory medicine, geriatrics and diabetes. She has co-ordinated and been chief investigator for a series of large-scale randomised clinical trials in cardiovascular disease, including the 20,000 participant MRC/BHF Heart Protection Study, the 12,000 patient SEARCH study, and the 25,000 patient HPS2-THRIVE study. In addition she is Chief Investigator for the BHF-supported ASCEND trial of aspirin and fish oils involving 15,000 people with diabetes. She also continues a clinical role in the Lipid Clinic at the Oxford University Hospital NHS Trust and has a particular interest in the safety of statins.
- Role of cholesterol and lipids (fats in the blood) in heart disease and stroke
- The use and safety of statins
- Role of other drugs to lower cholesterol, such as fibrates or niacin (also known as nicotinic acid)
- Estimation of the optimum dose of vitamin D for disease prevention in older people: Rationale, design and baseline characteristics of the BEST-D trial (2015)
- Effects of extended-release niacin with laropiprant in high-risk patients (2014)
- Pharmacogenomics of statin therapy: any new insights in efficacy or safety? (2014)
Professor Armitage has experience of working with the media.